| Literature DB >> 25617807 |
Claire Calmettes1, Stéphane Vigouroux2, Myriam Labopin3, Reza Tabrizi1, Pascal Turlure4, Xavier Lafarge5, Gérald Marit6, Arnaud Pigneux6, Thibaut Leguay1, Krimo Bouabdallah1, Marie-Sarah Dilhuydy1, Cédric Duclos1, Catherine Mohr1, Axelle Lascaux1, Pierre-Yves Dumas1, Sophie Dimicoli-Salazar1, Arnaud Saint-Lézer1, Noël Milpied6.
Abstract
We performed a retrospective study to identify pretransplantation risk factors for steroid-refractory (SR) acute graft-versus host disease (aGVHD) after allogeneic stem cell transplantation from matched donors in 630 adult patients who underwent transplantation at our center between 2000 and 2012. The cumulative incidence (CI) of SR aGVHD was 11.3% ± 2.3%. The identified independent risk factors were matched unrelated donor (hazard ratio [HR], 2.52; P = .001), female donor for male recipient (HR, 1.84; P = .023) and absence of antithymocyte globulin (HR, 2.02; P = .005). Three risk groups were defined according to the presence of these risk factors. In the whole cohort, the CI of SR aGVHD was 3.5% ± 1.7% in the low-risk group (0 risk factor, n = 115), 9.3% ± 1.6% in the intermediate-risk group (1 risk factor, n = 323), and 19.3% ± 2.9% in the high-risk group (2 or 3 risk factors, n = 192). Our study suggests that pretransplantation characteristics might help identify patients at high risk for SR aGVHD. A risk adapted first-line treatment of aGVHD could be evaluated in those patients.Entities:
Keywords: Risk factors; Steroid-refractory acute graft-versus-host disease
Mesh:
Year: 2015 PMID: 25617807 DOI: 10.1016/j.bbmt.2015.01.016
Source DB: PubMed Journal: Biol Blood Marrow Transplant ISSN: 1083-8791 Impact factor: 5.742